Fallopian Tube Diseases - 17 Studies Found

Recruiting : LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer
:
  • Epithelial Ovarian Cancer
  • Peritoneal Cancer
  • Fallopian Tube
    : 2016-01-21
    : Other: Diagnostic analysis Molecular profiling
Active, not recruiting : A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer
:
  • Ovarian Cancer
  • Fallopian Tube Cancer
  • Primary Peritoneal Ca
    : 2016-01-20
    :
    • Drug: Paclitaxel Please see ar
Recruiting : A Study of Long-Term Responders on Olaparib
:
  • Epithelial Ovarian Cancer
  • Fallopian Tube Cancer
  • Peritoneal
    : 2015-04-24
Not yet recruiting : A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
:
  • Ovarian Cancer
  • Fallopian Tube Cancer
  • Neoadjuvant Treatment
    : 2015-04-17
    :
    • Drug: Olaparib Other Name: Lyn
Active, not recruiting : Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
:
  • Ovarian Cancer
  • Primary Peritoneal Cancer
  • Fallopian Tube Ca
    : 2014-04-22
    :
    • Drug: Paclitaxel,
    • Drug: Bevacizumab
Recruiting : Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies
:
  • Advanced Epithelial Ovarian
  • Recurrent Epithelial Ovarian
  • F
    : 2013-10-25
    : Drug: Enzalutamide All enrolled patients will be treated with enzalutamide 160mg by mouth QD. Study drug
Completed : A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant Ovarian
: Primary Peritoneal Carcinoma
: 2013-09-18
:
  • Drug: Demcizumab administered

<<< Previous